IP Library › Granted Patent US 10,744,500
Granted Patent B2
US 10,744,500 · App. 15/858,077 · Granted Aug 18, 2020

Systems and methods for cellular separation

Inventors: Hannah McIntyre (Naples, FL); Christopher Bare (Naples, FL); Melissa Tucker (Estero, FL); Andrea Matuska (Naples, FL)
Assignee: ARTHREX, INC.
B01L3/502B01D21/26B01L3/50B01L3/508B01L3/523B01L2200/0631B01L2200/0689B01L2200/141B01L2300/042B01L2300/044B01L2300/048B01L2300/049B01L2300/0832B01L2300/123B01L2300/14B01L2400/0409
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,744,500
App. No.
15/858,077
Granted
Aug 18, 2020
Kind
B2
Abstract

Methods and systems disclosed herein provide systems and methods for maintaining sterile conditions inside of a biological-fluid container during an entire process of delivery, incubation, centrifugation, and extraction of fluid. The methods and systems also provide systems and methods for localized extraction of a portion of a biological fluid.

Claims (38)

1. A cap for a biological-fluid container, the cap comprising:

an injection port configured for injection of biological fluid through the injection port;

an extraction port configured for extraction of biological fluid through the extraction port;

an injection-port cap configured to attach to the injection port;

an extraction-port cap configured to attach to the extraction port, wherein at least one of the injection-port cap or the extraction-port cap is a vented cap; and a penetrable flexible seal configured for insertion and extraction of biological fluid through the flexible seal, wherein the flexible seal is present on the top of the cap for a biological-fluid container.

2. The cap of claim 1 , wherein the at least one vented cap is configured to release pressure from the biological-fluid container during insertion and extraction of biological fluid through the flexible seal via a needle.

3. The cap of claim 1 , wherein the injection port and extraction port each include a cannula configured to extend into the biological-fluid container.

4. The cap of claim 1 , wherein the injection port comprises a connection fitting configured to attach directly to a syringe or the injection-port cap, and wherein the extraction port comprises a connection fitting configured to attach directly to a syringe or the extraction-port cap.

5. The cap of claim 1 , wherein the penetrable flexible seal comprises a rubber stopper.

6. The cap of claim 1 , wherein the injection-port cap and the extraction-port cap are vented Luer caps.

7. The cap of claim 1 , further comprising a base configured to attach to the biological-fluid container.

8. The cap of claim 7 , wherein the base is attached to the biological-fluid container, and wherein the cap for a biological-fluid container provides a hermetic seal for the biological-fluid container.

9. The cap of claim 1 , wherein the injection-port cap is tethered to the injection port, and wherein the extraction-port cap is tethered to the extraction port.

10. The cap of claim 1 , wherein the injection port comprises threading to accommodate the injection-port cap, and wherein the extraction port comprises threading to accommodate the extraction-port cap.

11. The cap for a biological-fluid container of claim 1 , wherein the penetrable flexible seal is on the same plane on the cap for a biological-fluid container as the injection port and the extraction port.

12. A cellular-separation system comprising:

a biological-fluid container; and

a cap attached to the biological-fluid container, wherein the cap comprises:

an injection port configured for injection of biological fluid through the injection port;

an extraction port configured for extraction of biological fluid through the extraction port;

an injection-port cap configured to attach to the injection port;

an extraction-port cap configured to attach to the extraction port, wherein at least one of the injection-port cap or the extraction-port cap is a vented cap; and

a penetrable flexible seal configured for insertion and extraction of biological fluid through the flexible seal, wherein the flexible seal is present on the top of the cap for a biological-fluid container.

13. The cellular-separation system of claim 12 , wherein the biological-fluid container comprises a tubular body.

14. The cellular-separation system of claim 12 , further comprising a plurality of beads in the biological-fluid container.

15. The cellular-separation system of claim 14 , wherein the plurality of beads are suitable to activate Interleukin-I-Receptor Antagonist Protein.

16. The cellular-separation system of claim 12 , wherein the at least one vented cap is configured to release pressure from the biological-fluid container during insertion and extraction of biological fluid through the flexible seal via a needle.

17. The cellular-separation system of claim 12 , wherein the cap for a biological-fluid container hermetically seals the biological-fluid container.

18. The cellular-separation system of claim 12 , wherein the injection port and extraction port each include a cannula configured to extend into the biological-fluid container.

19. The cellular-separation system of claim 12 , wherein the penetrable flexible seal comprises a rubber stopper.

20. The cellular-separation system of claim 12 , wherein the injection-port cap and the extraction-port cap are both vented caps.

21. A method to isolate one or more fractions of a biological fluid, the method comprising:

injecting a biological fluid into a biological-fluid container through an injection port in a cap of the cellular-separation system of claim 12 , wherein the injection port is configured to attach to a vented cap;

incubating the biological fluid injected into the biological-fluid container;

centrifuging the biological-fluid container to form two or more fractions of the biological fluid; and

removing one or more fractions of the biological fluid from the biological-fluid container through the penetrable flexible seal in the cap, wherein during said removing the vented cap is attached to the injection port and releases pressure from the biological-fluid container.

22. The method of claim 21 , wherein the vented cap is attached to the injection port during said injecting, and wherein said injecting comprises injecting blood through the vented cap.

23. The method of claim 21 , wherein the biological fluid is blood, wherein the biological-fluid container has a plurality of beads to activate protein production in the blood, wherein incubating the biological-fluid container comprises incubating the biological-fluid container for a sufficient time and at a sufficient temperature to produce a therapeutically active protein in the blood, and wherein centrifuging the biological-fluid container to form two or more fractions of the biological fluid comprises centrifuging the biological-fluid container to form a serum containing the therapeutically active protein.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jan 18, 2018
From: MCINTYRE, HANNAH; BARE, CHRISTOPHER; TUCKER, MELISSA; MATUSKA, ANDREA
To: ARTHREX, INC.
Reel/Frame 044659/0040 →
Continuity (1)
Related Publication 20190201888A1 · Jul 4, 2019